Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma
Phase 1 Completed
19 enrolled
Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma
Phase 1 Completed
10 enrolled
CAR T Cells in Mesothelin Expressing Cancers
Phase 1 Completed
65 enrolled 14 charts
8479217
Phase 1 Completed
6 enrolled 17 charts
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Phase 1 Completed
22 enrolled
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Phase 1 Completed
15 enrolled
NVB Metro
Phase 1 Completed
30 enrolled
Dasatinib in Resectable Malignant Pleural Mesothelioma
Phase 1 Completed
56 enrolled
A Study of LY3023414 in Participants With Advanced Cancer
Phase 1 Completed
156 enrolled
Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma
Phase 1 Completed
18 enrolled
Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Phase 1 Completed
60 enrolled 15 charts
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Phase 1 Completed
Gene Therapy for Pleural Malignancies
Phase 1 Completed
17 enrolled
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies
Phase 1 Completed
34 enrolled
Autologous Redirected RNA Meso-CIR T Cells
Phase 1 Completed
18 enrolled
Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT)
Phase 1 Completed
11 enrolled
MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC
Phase 1 Completed
27 enrolled
Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma
Phase 1 Completed
141 enrolled
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma
Phase 1 Completed
22 enrolled 7 charts
Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
Phase 1 Completed
19 enrolled
IFN-alpha
Phase 1 Completed
13 enrolled
Immunotoxin Therapy in Treating Patients With Advanced Cancer
Phase 1 Completed
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura
Phase 1 Completed
Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma
Phase 1 Completed
70 enrolled
Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
Phase 1 Completed
6 enrolled
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
Phase 1 Completed
75 enrolled
Interleukin-12 in Treating Patients With Cancer in the Abdomen
Phase 1 Completed
29 enrolled
Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs
Phase 1 Completed
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Completed
75 enrolled
PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer
Phase 1 Completed
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma
Phase 1 Completed
20 enrolled
Dendritic Cell-based Immunotherapy in Mesothelioma
Phase 1 Completed
10 enrolled